Article
Viral hepatitis B.
Lancet (London, England) - 20 Dec 2003
Lai Ching Lung, Ratziu Vlad, Yuen Man-Fung, Poynard Thierry
Abstract excerpt
More than 400 million people worldwide are chronically infected by the hepatitis B virus. The virus is responsible for more than 300000 cases of liver cancer every year and for similar numbers of gastrointestinal haemorrhage and ascites. Major breakthroughs have been achieved in diagnosis and treatment of this virus. Hepatitis B vaccine reduces incidence of liver cancer. As with hepatitis C, advances have been...
Topics
- Adenine
- Antiviral Agents
- Comorbidity
- Drug Therapy, Combination
- Genotype
- HIV Infections
- Hepatitis B
- Hepatitis B virus
- Hepatitis B, Chronic
- Humans
- Interferon-alpha
- Lamivudine
- Organophosphonates
- Reverse Transcriptase Inhibitors
- Viral Load